At WindMIL Therapeutics®, we are dedicated to our mission: Translating novel insights in bone marrow immunology into life-saving cell therapies for cancer patients.
The bone marrow has an important role in the immune system, acting as a reservoir of persistent immune cells generated as a response to foreign antigens. Our proprietary process creates a cellular product called MILs® (Marrow Infiltrating Lymphocytes) that contains these activated tumor-targeting memory T cells.
We aim to leverage our deep understanding of the unique immunologic properties of the bone marrow to lead the way in cancer cell therapies, but also to fulfill our commitment to helping patients live a longer, healthier life.